Wordt geladen...
Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α
BACKGROUND: Epidermal growth factor receptor (EGFR) overexpression is associated with the development of head and neck cancer (HNC) and represents one of the main therapeutic targets for this disease. The use of EGFR inhibitors has limited efficacy due to their primary and acquired resistance, parti...
Bewaard in:
| Gepubliceerd in: | Br J Cancer |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461861/ https://ncbi.nlm.nih.gov/pubmed/30765872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0394-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|